• Universe Pharmaceuticals issued 71,890 Class A ordinary shares and 12,610 Class B ordinary shares to CEO Gang Lai under its 2026 Equity Incentive Plan, as compensation for past services.
• Shares were issued May 7, 2026, following plan adoption on April 14, 2026.
• Post-issuance share count totals 631,761 Class A ordinary shares, 16,077 Class B ordinary shares outstanding; Class B shares convert 1-for-1 into Class A.
• Lai and his holding company now control about 75% of total voting power.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universe Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-056617), on May 14, 2026, and is solely responsible for the information contained therein.